Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease
暂无分享,去创建一个
Gregory J. Gores | Lewis R. Roberts | G. Gores | L. Roberts | Ju Dong Yang | A. Allen | K. Mara | Fowsiyo Ahmed | Kristin C. Mara | Benyam D. Addissie | Alina M. Allen | B. Addissie | Fowsiyo Ahmed | J. Yang | J. D. Yang
[1] V. Castranova,et al. Beyond apoptosis of JNK1 in liver cancer , 2009, Cell cycle.
[2] N. Kawada,et al. The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease , 2020, International journal of molecular sciences.
[3] M. Karin,et al. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[4] G. Gores,et al. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[5] E. Bugianesi,et al. Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease , 2016, PloS one.
[6] Steven J. M. Jones,et al. Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma , 2017, Cell.
[7] A. Gasbarrini,et al. Diabetes and Insulin Therapy, but Not Metformin, Are Related to Hepatocellular Cancer Risk , 2015, Gastroenterology research and practice.
[8] L. Henry,et al. Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes , 2016, Hepatology.
[9] J. Bruix,et al. Management of hepatocellular carcinoma: An update , 2011, Hepatology.
[10] M. Manns,et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus , 2008, Hepatology.
[11] M. Crossley,et al. Observational Research Methods , 1987 .
[12] C. Mann,et al. Observational research methods. Research design II: cohort, cross sectional, and case-control studies , 2003, Emergency medicine journal : EMJ.
[13] C. Byrne,et al. Diabetes is associated with increased risk of hepatocellular carcinoma in non-alcoholic steatohepatitis with cirrhosis-implications for surveillance and future pharmacotherapy. , 2020, Hepatobiliary surgery and nutrition.
[14] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[15] Zhiwen Liu,et al. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta‐analysis , 2012, Diabetes/metabolism research and reviews.
[16] T. Therneau,et al. Hepatocellular carcinoma in olmsted county, Minnesota, 1976-2008. , 2012, Mayo Clinic proceedings.
[17] W. Kim,et al. De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era , 2018, Hepatology.
[18] W. Kim,et al. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis , 2016, The American Journal of Gastroenterology.
[19] Giorgio Saracco,et al. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study , 2011, Hepatology.
[20] Puneet Puri,et al. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[21] A. Boonstra,et al. NAFLD‐Related Hepatocellular Carcinoma and the Four Horsemen of the Apocalypse , 2020, Hepatology.
[22] O. Ohara,et al. Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC , 2018, Cell.
[23] Michael Karin,et al. A central role for JNK in obesity and insulin resistance , 2002, Nature.
[24] T. Joh,et al. Albumin Suppresses Human Hepatocellular Carcinoma Proliferation and the Cell Cycle , 2014, International journal of molecular sciences.
[25] G. Gores,et al. Recent Trends in the Epidemiology of Hepatocellular Carcinoma in Olmsted County, Minnesota: A US Population-based Study , 2017, Journal of clinical gastroenterology.
[26] L. Carbone,et al. Incidence of altered glucose tolerance in liver cirrhosis. , 1993, Diabetes research and clinical practice.
[27] E. Wagner,et al. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. , 2008, The Journal of clinical investigation.
[28] B. Graubard,et al. Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States , 2013, The American Journal of Gastroenterology.
[29] B. Carr,et al. Role of Albumin in Growth Inhibition in Hepatocellular Carcinoma , 2017, Oncology.
[30] B. Naini,et al. Metabolic factors affecting hepatocellular carcinoma in steatohepatitis , 2018, Liver international : official journal of the International Association for the Study of the Liver.
[31] S. Altekruse,et al. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] Rohit Loomba,et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease , 2017, Hepatology.
[33] T. Therneau,et al. Factors that affect risk for hepatocellular carcinoma and effects of surveillance. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[34] Shelly C. Lu,et al. NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances , 2018, The American Journal of Gastroenterology.
[35] G. Ioannou,et al. Differences in hepatocellular carcinoma risk, predictors and trends over time according to etiology of cirrhosis , 2018, PloS one.
[36] H. El‐Serag,et al. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[37] J. Samet,et al. Fasting serum glucose level and cancer risk in Korean men and women. , 2005, JAMA.
[38] S. Asch,et al. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. , 2018, Gastroenterology.
[39] H. El‐Serag,et al. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. , 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[40] S. Satapathy,et al. Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates . , 2020, Translational gastroenterology and hepatology.
[41] J. Shieh,et al. Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies , 2012, Gut.
[42] Robert A Fisher,et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C , 2006, Hepatology.
[43] M. Manns,et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. , 2018, Journal of hepatology.
[44] E. Tapper,et al. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study , 2018, British Medical Journal.
[45] Rocio Lopez,et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis , 2010, Hepatology.
[46] E. Calle,et al. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms , 2004, Nature Reviews Cancer.
[47] Kuo-Chin Huang,et al. Diabetes and hepatocellular carcinoma risks in patients with nonalcoholic steatohepatitis related cirrhosis. , 2020, Hepatobiliary surgery and nutrition.